Psychedelics Today
Psychedelics Today
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
Episodes
Mentioned books
Jan 6, 2023 • 40min
Psychedelics Weekly – Psilocybin-Assisted Psychotherapy for I.B.S., NY Aims to Legalize, and B.C.’s Decriminalization Experiment
In this episode, David and Joe discuss Tryp Therapeutics researching psilocybin-assisted psychotherapy for I.B.S.; NY lawmakers pre-filing a bill to legalize natural psychedelics; and British Columbia decriminalizing drugs. www.psychedelicstoday.com
Jan 3, 2023 • 1h 23min
PT380 – C.J. Spotswood, PMHNP-BC – Microdosing, Talking to Physicians About Psychedelics, and Nurses as the Scalability Solution
In this episode, Kyle interviews author and board-certified psychiatric-mental health nurse practitioner, C.J. Spotswood. They discuss microdosing and why nurses could be the answer to the psychedelics and scalability problem. www.psychedelicstoday.com
Dec 30, 2022 • 35min
Psychedelics Weekly – Psilocybin and Stress Response, the Minnesota Medical Association Endorses Decriminalization, and Scott Wiener Introduces Senate Bill 58
In this episode, Joe and Kyle cover a study where psilocybin improved stress response; The Economist highlighting psychedelic medicine as a main story for 2023; and the Minnesota Medical Association endorsing decriminalization. www.psychedelicstoday.com
Dec 27, 2022 • 1h 21min
PT379 – Sutton King, MPH – Intergenerational Trauma, Late-Stage Capitalism, and the Urban Indigenous Collective
In this episode, David interviews internationally recognized Indigenous rights activist: Sutton King, MPH. She discusses the challenges Indigenous people continue to face from intergenerational trauma, and their resiliency. www.psychedelicstoday.com
Dec 23, 2022 • 34min
Psychedelics Weekly – Prop 122 and Data Privacy, Ending the Crack/Cocaine Sentencing Disparity, and the High Cost of Psychedelic Therapy
In this episode, Joe and Kyle discuss concerns over Prop 122 and data privacy, the hopeful end to the sentencing disparity between crack cocaine and powder; and the cost vs. value problem of psychedelic therapy: is it worth it? www.psychedelicstoday.com
Dec 20, 2022 • 1h 9min
PT378 – Zach Leary – Course Corrections, Preparation, and High-dose Experiences: "Who Are You Now?"
In this episode, Joe interviews Zach Leary: author, facilitator, trainer, host of the MAPS podcast, and of course, son of psychedelic legend: Timothy Leary. They discuss Ram Dass, Michael Pollan, flotation tanks, and more. www.psychedelicstoday.com
Dec 16, 2022 • 46min
Psychedelics Weekly – Proposition 122 in Action, The Economics of Psychedelics, and Could States Legalize by 2037?
In this episode, Joe & David discuss the DA dropping a felony drug charge against a Denver mushroom rabbi, the economics of psychedelic-assisted therapies, and the belief that most US states will legalize psychedelics by 2037. www.psychedelicstoday.com
Dec 13, 2022 • 60min
PT377 – Andrew Weil, M.D. – Integrative Medicine: Health, Wellness, and Psychedelics
In this episode, Joe interviews New York Times best-selling author, pioneer in the field of integrative medicine, legend in the health and wellness space, and (somewhat surprising to us) psychedelic advocate, Andrew Weil, M.D. www.psychedelicstoday.com
Dec 9, 2022 • 1h
Psychedelics Weekly – Genetic Memory, "The Psychedelic Renaissance," and Harm Reduction at Music Festivals
In this episode of Psychedelics Weekly, Joe and David discuss methylation and genetic memory; why the term, “The Psychedelic Renaissance” is problematic; and the importance of harm reduction – especially at music festivals. www.psychedelicstoday.com
14 snips
Dec 6, 2022 • 1h 13min
PT376 – Sherry Rais – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits
Sherry Rais, CEO/Co-Founder of Enthea, discusses offering psychedelic therapy through employer health plans, personal anecdotes on running and cultural influences, advocating for mental health equity, expanding access to psychedelic therapy services, implementing ketamine-assisted therapy for employers, and the global deployment of psychedelic medicines.
